Therapies for hematologic malignancies

Details for Australian Patent Application No. 2009313878 (hide)

Owner Calistoga Pharmaceuticals Inc.

Inventors Gallatin, Michael W.; Ulrich, Roger G.; Giese, Neill

Agent Pizzeys

Pub. Number AU-A-2009313878

PCT Pub. Number WO2010/057048

Priority 61/180,768 22.05.09 US; 61/231,278 04.08.09 US; 61/142,845 06.01.09 US; 61/155,057 24.02.09 US; 61/114,434 13.11.08 US; 61/245,196 23.09.09 US

Filing date 13 November 2009

Wipo publication date 20 May 2010

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/057048 Priority application(s): WO2010/057048

5 July 2012 Alteration of Name

  The name of the applicant has been altered to Gilead Calistoga LLC 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313879-Ingestible therapy activator system and method

2009313877-CD37 immunotherapeutic combination therapies and uses thereof